<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03941899</url>
  </required_header>
  <id_info>
    <org_study_id>0081052</org_study_id>
    <nct_id>NCT03941899</nct_id>
  </id_info>
  <brief_title>The Analgesic Effect of QLB II After Robotic Prostatectomy. (QLB II: Quadratus Lomborum Block II Type)</brief_title>
  <acronym>QLBII</acronym>
  <official_title>The Analgesic Effect of Qudratus Lomborum Block II Type After Robotic-Assisted Laparoscopic Radical Prostatectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Salvatore Hospital of L'Aquila</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>San Salvatore Hospital of L'Aquila</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The analgesic effects of Quadratus Lomborum Block II type after robotic-assisted laparoscopic
      radical prostatectomy, will be assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Quadratus Lomborum Block II type will be performed before performing robotic-assisted
      laparoscopic radical prostatectomy.

      The post-operative analgesic effect will be assessed, by using Numeric Rate Scale for pain.

      The pain assessment will be evaluated during the first 24 hours from surgery. The opioids
      requirement and side effects will be also assessed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 6, 2019</start_date>
  <completion_date type="Anticipated">May 6, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 6, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Simon's Two-Stage single arm study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analgesia</measure>
    <time_frame>The first 24 hours from surgery</time_frame>
    <description>Pain assessment by using Numeric Rate Scale for pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioids</measure>
    <time_frame>The first 24 hours from surgery</time_frame>
    <description>The opioids requirement (mg of equianalgesic morphine) will be assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Nausea and Vomiting</measure>
    <time_frame>The first 24 hours from surgery</time_frame>
    <description>The postoperative nausea and vomiting will be assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel function</measure>
    <time_frame>The first 24 hours from surgery</time_frame>
    <description>The recovery of bowel function will be assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>Day after surgery</time_frame>
    <description>The length of stay after surgery will be assessed</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>QLB II</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Quadratus Lomborum Blocck II type will be performed before robot-assisted laparoscopic radical prostatectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Levobupivacaine in QLB II</intervention_name>
    <description>Quadratus Lomborum Block II type will be performed by injecting levobupivacaine 0.375% 20 ml between latissimus dorsi and quadratus lomborum muscle.</description>
    <arm_group_label>QLB II</arm_group_label>
    <other_name>Quadratus Lomborum Block II type</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologist status I-III

          -  Written informed consent

        Exclusion Criteria:

          -  Body mass Index &gt; 35 kg/m2

          -  Allergies to local anesthetics

          -  primaries or secondaries coagulopathies

          -  addiction to drugs

          -  severe kidney and liver diseases

          -  cognitive impairment
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Patients undergoing to robotic-assisted laparoscopic radical prostatectomy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franco Marinangeli, MD</last_name>
    <role>Study Chair</role>
    <affiliation>San Salvatore Academic Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emiliano Petrucci, MD</last_name>
    <phone>+39 0862 3681</phone>
    <email>petrucciemiliano@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Piefrancesco Fusco, MD</last_name>
    <phone>+39 0862 3681</phone>
    <email>pierfrancescofusco@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>San Salvatore Academic Hospital</name>
      <address>
        <city>Coppito</city>
        <state>L'Aquila</state>
        <zip>67100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierfrancesco Fusco, MD</last_name>
      <phone>+39 0862 368647</phone>
      <email>protocollogenerale@pec.asl1abruzzo.it</email>
    </contact>
    <contact_backup>
      <last_name>Franco Marinangeli, MD</last_name>
      <phone>+39 0862 368648</phone>
      <email>fmarinangeli@asl1abruzzo.it</email>
    </contact_backup>
    <investigator>
      <last_name>Petrucci Emiliano, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scimia Paolo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Di Carlo Stefano, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>De Sanctis Francesca, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincenza Cofini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefano Necozione</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 6, 2019</study_first_submitted>
  <study_first_submitted_qc>May 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2019</study_first_posted>
  <last_update_submitted>May 9, 2019</last_update_submitted>
  <last_update_submitted_qc>May 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>San Salvatore Hospital of L'Aquila</investigator_affiliation>
    <investigator_full_name>Emiliano Petrucci</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pain, radical prostatectomy, QLB II type</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

